FMR LLC - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 66 filers reported holding HOMOLOGY MEDICINES INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
FMR LLC ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q3 2023$74,309
+27.2%
63,512
-3.8%
0.00%
Q2 2023$58,426
-61.9%
66,018
-55.7%
0.00%
Q1 2023$153,324
+91.5%
148,858
+134.2%
0.00%
Q4 2022$80,073
-84.6%
63,550
-80.4%
0.00%
Q3 2022$521,000
-63.1%
323,754
-54.8%
0.00%
Q2 2022$1,411,000
-45.8%
715,999
-16.4%
0.00%
Q1 2022$2,604,000
-42.9%
856,439
-31.7%
0.00%
Q4 2021$4,561,000
-53.8%
1,253,0910.0%0.00%
-100.0%
Q3 2021$9,862,000
+8.3%
1,253,0910.0%0.00%0.0%
Q2 2021$9,110,000
+92.5%
1,253,091
+149.1%
0.00%
Q1 2021$4,733,000
-54.9%
503,008
-45.9%
0.00%
-100.0%
Q4 2020$10,503,000
-44.5%
930,308
-47.4%
0.00%
-50.0%
Q3 2020$18,918,000
-44.2%
1,768,008
-20.8%
0.00%
-50.0%
Q2 2020$33,927,000
-0.9%
2,233,508
+1.4%
0.00%
-20.0%
Q1 2020$34,224,000
-23.7%
2,202,323
+1.6%
0.01%0.0%
Q4 2019$44,867,000
+16.6%
2,167,479
+2.0%
0.01%0.0%
Q3 2019$38,464,000
-8.7%
2,125,056
-1.3%
0.01%0.0%
Q2 2019$42,123,000
-28.0%
2,152,445
+2.0%
0.01%
-28.6%
Q1 2019$58,515,000
+24.0%
2,110,161
-0.0%
0.01%
+16.7%
Q4 2018$47,197,000
-12.2%
2,110,756
-10.3%
0.01%0.0%
Q3 2018$53,776,000
-20.0%
2,352,416
-30.0%
0.01%
-25.0%
Q2 2018$67,192,000
+26.4%
3,359,715
+12.9%
0.01%
+33.3%
Q1 2018$53,163,0002,974,8970.01%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q4 2018
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,535,919$8,936,0002.21%
Vida Ventures Advisors, LLC 770,845$1,519,0001.28%
OUP Management Co., LLC 64,000$126,0000.17%
Oasis Management Co Ltd. 280,000$552,0000.10%
Vivo Capital, LLC 370,068$729,0000.07%
AAF Wealth Management, LLC 47,501$94,0000.07%
TANG CAPITAL MANAGEMENT LLC 214,898$423,0000.06%
Temasek Holdings (Private) Ltd 5,650,996$11,132,4620.06%
Bellevue Group AG 1,622,522$3,196,0000.04%
GSA CAPITAL PARTNERS LLP 128,353$253,0000.04%
View complete list of HOMOLOGY MEDICINES INC shareholders